BioLineRx (BLRX) Enterprise Value Growth (1y) (2011 - 2025)
BioLineRx (BLRX) Enterprise Value Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.60% |
| Sep 30, 2025 | 13.58% |
| Jun 30, 2025 | 29.71% |
| Mar 31, 2025 | 6.40% |
| Dec 31, 2024 | 54.50% |
| Sep 30, 2024 | -12.34% |
| Jun 30, 2024 | -22.08% |
| Mar 31, 2024 | 34.92% |
| Dec 31, 2023 | 15.83% |
| Sep 30, 2023 | 54.65% |
| Jun 30, 2023 | 23.94% |
| Mar 31, 2023 | 14.44% |
| Dec 31, 2022 | 10.59% |
| Sep 30, 2022 | 7.95% |
| Jun 30, 2022 | 34.20% |
| Mar 31, 2022 | 12.90% |
| Dec 31, 2021 | -152.96% |
| Sep 30, 2021 | -198.67% |
| Jun 30, 2021 | -140.15% |
| Mar 31, 2021 | -174.22% |